Korro Bio Files 8-K/A Amendment
Ticker: KRRO · Form: 8-K/A · Filed: Jun 18, 2025 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K/A |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, filing-update
TL;DR
Korro Bio filed an amendment to a shareholder vote filing. Nothing new, just fixing paperwork.
AI Summary
Korro Bio, Inc. filed an 8-K/A on June 18, 2025, to amend a previous filing regarding the submission of matters to a vote of security holders. The original event date was June 11, 2025. The company, formerly known as Frequency Therapeutics, Inc., is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This filing is an amendment to a previous report concerning shareholder votes, indicating a procedural update or correction related to corporate governance matters.
Risk Assessment
Risk Level: low — This is an administrative amendment to a previous filing, not a new event with significant financial or operational implications.
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- Frequency Therapeutics, Inc. (company) — Former company name
- June 11, 2025 (date) — Earliest event date
- June 18, 2025 (date) — Filing date
- Delaware (location) — State of incorporation
- Cambridge, MA (location) — Principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report concerning the submission of matters to a vote of security holders.
When was the earliest event reported in this filing?
The earliest event reported was on June 11, 2025.
What is Korro Bio, Inc.'s former name?
Korro Bio, Inc.'s former name was Frequency Therapeutics, Inc.
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc. is headquartered at 60 First Street, 2nd floor, Suite 250, Cambridge, MA 02141.
What is the filing date of this 8-K/A?
This 8-K/A was filed as of June 18, 2025.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 18, 2025 regarding Korro Bio, Inc. (KRRO).